Welcome to LookChem.com Sign In|Join Free

CAS

  • or
N1-(2-CHLORO-6-FLUORO-3-NITROPHENYL)ACETAMIDE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

218796-15-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 218796-15-7 Structure
  • Basic information

    1. Product Name: N1-(2-CHLORO-6-FLUORO-3-NITROPHENYL)ACETAMIDE
    2. Synonyms: N1-(2-CHLORO-6-FLUORO-3-NITROPHENYL)ACETAMIDE;N-(2-Chloro-6-fluoro-3-nitrophenyl)acetamide
    3. CAS NO:218796-15-7
    4. Molecular Formula: C8H6ClFN2O3
    5. Molecular Weight: 232.6
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 218796-15-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. CAS DataBase Reference: N1-(2-CHLORO-6-FLUORO-3-NITROPHENYL)ACETAMIDE(CAS DataBase Reference)
    10. NIST Chemistry Reference: N1-(2-CHLORO-6-FLUORO-3-NITROPHENYL)ACETAMIDE(218796-15-7)
    11. EPA Substance Registry System: N1-(2-CHLORO-6-FLUORO-3-NITROPHENYL)ACETAMIDE(218796-15-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 218796-15-7(Hazardous Substances Data)

218796-15-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 218796-15-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,8,7,9 and 6 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 218796-15:
(8*2)+(7*1)+(6*8)+(5*7)+(4*9)+(3*6)+(2*1)+(1*5)=167
167 % 10 = 7
So 218796-15-7 is a valid CAS Registry Number.

218796-15-7Relevant articles and documents

BENZOTHIAZOLE COMPOUNDS AND USES THEREOF

-

Paragraph 0400-0401, (2020/02/27)

Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associate

BENZIMIDAZOLE AND INDOLE COMPOUNDS AND USES THEREOF

-

Paragraph 0549; 0554-0555, (2019/10/29)

Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associate

MOLECULES HAVEING PESTICIDAL UTILIY AND INTERMEDIATES, COMPOSITIONS AND PROCESSES RELATED THERETO

-

Paragraph 1669, (2018/04/20)

This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions containing such molecules, and processes of using such pesticidal compositions against such pests. These pesticidal compositions may be used, for example, as acaricides, insecticides, miticides, molluscicides, and nematicides. This document discloses molecules having the following formula (“Formula One”).

NEW TRIAZOLYLPHENYL SULFONAMIDES AS SERINE/THREONINE KINASE INHIBITORS

-

Page/Page column 40, (2012/07/13)

The present invention encompasses compounds of general formula (I) wherein the groups R2 to R4, A,X and m are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain compounds of this kind and their use as medicaments.

Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors

-

Page/Page column 18, (2013/02/27)

The present invention encompasses compounds of general formula (I) wherein the groups R2 to R4, A, X and m are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain compounds of this kind and their use as medicaments.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 218796-15-7